03 Jan 2023
Navigating Uncertainties in the 340B Drug Pricing Program
Learn about the regulatory background that set the stage for recent 340B Program developments and get guidance on how to navigate 340B regulatory inflection points and favorably position your clients for the future of the 340B Program.
Related Content
- Life Sciences Post-Closing Price Reporting Covenant Clause
Draft contractual obligations to comply with price reporting rules affecting parties that participate in government sponsored health care programs, such as Medicare or Medicaid.
- Prescription Cost Control Assistance State Law Survey
Research state laws and regulations controlling prescription drug prices and programs providing for assistance in accessing drugs.
Practical Guidance Updates
Featuring the latest updates from your Practical Guidance account.
- Listen up! Access our growing collection of podcasts by navigating to the Practical Guidance and Law 360 Podcasts Resource Kit.
- Legal Developments provide the latest updates and analyses of emerging topics impacting your practice area. Visit the Legal Developments page to see the latest topics, which also include breaking legal news and related Practical Guidance content
- Check out the new Practical Guidance Author Center! Learn about the 1750+ leading attorney authors contributing to our 22 practice areas, and find out how you can Become a Practical Guidance Author.
- The Practical Guidance Journal Fall Edition features impacts of the Dobbs v. Jackson Health Organization decision on employers, healthcare, insurance, and privacy concerns, and tracks the status of state law changes.
- Document alerts allow you to stay current on legal developments that affect your practice. Find out how to set up your document alerts.
Experience results today with practical guidance, legal research, and data-driven insights—all in one place.
Experience Lexis+